Qurgen
PrivateLast Round
VC Round
Jan 1, 2023
Total Funding Raised
$4M
Company Overview
Qurgen is a biotechnology company that develops protein-based regenerative medicine and transcription factor drugs to treat cancer, heart failure, diabetes, and other serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qurgen Comparables
Compare Qurgen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stemgenics, Inc. | 78% | |
| Reprogram Biosciences | 76% | |
| Asgard Therapeutics | 76% | |
Qurgen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 1, 2023 |
Qurgen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Monthly visitors increased 70% MoM.
- Jan 1, 2023
$55M raised in a VC Round.
Qurgen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Qurgen's valuation, stock price, and market status.